Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
Ariza
Javier
J
Servicio de Enfermedades Infecciosas, Hospital de Bellvitge, Universidad deBarcelona, Barcelona, Spain.
Bosilkovski
Mile
M
Cascio
Antonio
A
Colmenero
Juan D
JD
Corbel
Michael J
MJ
Falagas
Matthew E
ME
Memish
Ziad A
ZA
Roushan
Mohammad Reza Hasanjani
MR
Rubinstein
Ethan
E
Sipsas
Nikolaos V
NV
Solera
Javier
J
Young
Edward J
EJ
Pappas
Georgios
G
D000818:Animals; D000900:Anti-Bacterial Agents / Q000266:history / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D002006:Brucellosis / Q000145:classification / Q000188:drug therapy* / Q000266:history / Q000382:microbiology; D003906:Developing Countries; D004318:Doxycycline / Q000627:therapeutic use; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D014943:Global Health; D019983:Guideline Adherence; D049674:History, 21st Century; D006801:Humans; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D009626:Terminology as Topic; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014944:World Health Organization
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D024841:Fluoroquinolones; D005839:Gentamicins; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D004318:Doxycycline; D012293:Rifampin; D013307:Streptomycin